Friday, January 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Immersion Faces Nasdaq Compliance Challenge Over Delayed Filing

Andreas Sommer by Andreas Sommer
September 4, 2025
in Earnings, Nasdaq, Tech & Software
0
Immersion Stock
0
SHARES
202
VIEWS
Share on FacebookShare on Twitter

Shares of Immersion Corporation came under scrutiny after the haptics technology specialist received a formal notification from the Nasdaq stock market regarding a compliance issue. The alert, issued on August 20, 2025, stems from the company’s failure to timely file its Annual Report on Form 10-K for the fiscal year that concluded on April 30, 2025.

The delay is directly connected to an ongoing internal investigation being conducted by the audit committee of Barnes & Noble Education (BNED), a subsidiary of Immersion. This development has introduced significant uncertainty for investors, prompting heightened attention to the company’s regulatory compliance efforts.

Key Details of the Notification:
* Notification Date: August 20, 2025
* Nature of Breach: Late submission of the Form 10-K annual report
* Root Cause: Internal probe at subsidiary Barnes & Noble Education (BNED)
* Response Deadline: 60 calendar days to submit a plan to regain compliance

Should investors sell immediately? Or is it worth buying Immersion?

In response to the notification, Immersion now has a 60-day window to present a detailed plan to Nasdaq outlining its path to rectifying this filing delinquency. A failure to satisfy the exchange’s requirements could lead to further disciplinary actions, including the potential for the stock’s delisting.

Reflecting the cautious market sentiment, Immersion’s stock closed its latest session at $7.01. The immediate focus for the company is squarely on resolving the filing delay and navigating the complexities of the internal investigation at BNED.

Despite these recent regulatory headwinds, some market analysts maintain a measured outlook on the stock’s potential. The current average price target among covering analysts stands at $12.25. This figure suggests a substantial upside potential of over 75% from the recent closing price of $6.99. While the average broker recommendation has softened from 1.50 to 2.00, it continues to signal an overall positive assessment of the company’s long-term value.

Ad

Immersion Stock: Buy or Sell?! New Immersion Analysis from January 23 delivers the answer:

The latest Immersion figures speak for themselves: Urgent action needed for Immersion investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 23.

Immersion: Buy or sell? Read more here...

Tags: Immersion
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Cognizant Stock
AI & Quantum Computing

Cognizant Shares Gain Momentum Ahead of Earnings Report

January 23, 2026
Arcutis Biotherapeutics Stock
Analysis

Arcutis Biotherapeutics Schedules Fourth Quarter and Full-Year 2025 Earnings Release

January 23, 2026
Fiserv Stock
Analysis

Fiserv’s Strategic Crossroads: Balancing Expansion with Investor Confidence

January 23, 2026
Next Post
G1 Therapeutics Stock

G1 Therapeutics Acquisition Finalized in Landmark $405M Deal

Monopar Therapeutics Stock

Monopar Therapeutics Stock Surges on Clinical Progress and Analyst Optimism

Voyager Therapeutics Stock

Voyager Therapeutics Stock Gains Momentum Following Investor Conference Appearances

Recommended

Biotechnology Stock Market Today (1)

Thermo Fisher Scientific Receives Positive Analyst Ratings and Increased Price Targets

2 years ago
Oxford Lane Capital Stock

Oxford Lane Capital Faces Dividend Test Amid Market Volatility

2 months ago
Marvell Technology Stock

Marvell Technology Stock: AI-Driven Rally Sparks Investor Optimism

2 months ago
PepsiCo Stock

Can Pepsi’s Q3 Earnings Spark a Turnaround for Its Struggling Stock?

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Fiserv’s Strategic Crossroads: Balancing Expansion with Investor Confidence

Political Headwinds Challenge Coinbase’s Regulatory Strategy

Take-Two Shares Navigate a Holding Pattern Ahead of Grand Theft Auto VI Launch

Cardano Approaches a Technical and Fundamental Inflection Point

Salesforce at a Crossroads: AI Ambition Meets Market Anxiety

Oracle’s Strategic Gambit: A High-Stakes Clash Between TikTok Deal and Bearish Bets

Trending

Cognizant Stock
AI & Quantum Computing

Cognizant Shares Gain Momentum Ahead of Earnings Report

by Felix Baarz
January 23, 2026
0

A wave of positive analyst sentiment is building around Cognizant Technology Solutions in the days leading up...

BYD Stock

BYD’s Global Expansion Strategy Gains Momentum

January 23, 2026
Arcutis Biotherapeutics Stock

Arcutis Biotherapeutics Schedules Fourth Quarter and Full-Year 2025 Earnings Release

January 23, 2026
Fiserv Stock

Fiserv’s Strategic Crossroads: Balancing Expansion with Investor Confidence

January 23, 2026
Coinbase Stock

Political Headwinds Challenge Coinbase’s Regulatory Strategy

January 23, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cognizant Shares Gain Momentum Ahead of Earnings Report
  • BYD’s Global Expansion Strategy Gains Momentum
  • Arcutis Biotherapeutics Schedules Fourth Quarter and Full-Year 2025 Earnings Release

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com